enow.com Web Search

  1. Ads

    related to: hyperphosphatemia treatment nice list of drugs for diabetes

Search results

  1. Results from the WOW.Com Content Network
  2. Sevelamer - Wikipedia

    en.wikipedia.org/wiki/Sevelamer

    Sevelamer is a phosphate binding medication used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals.

  3. Phosphate binder - Wikipedia

    en.wikipedia.org/wiki/Phosphate_binder

    There have been limited trials comparing phosphate binders to placebo in the treatment of hyperphosphatemia in people with chronic kidney disease. When compared with people receiving calcium-based binders, people taking sevelamer have a reduced all-cause mortality. [4]

  4. Hyperphosphatemia - Wikipedia

    en.wikipedia.org/wiki/Hyperphosphatemia

    The diagnosis of hyperphosphatemia is made through measuring the concentration of phosphate in the blood. A phosphate concentration greater than 1.46 mmol/L (4.5 mg/dL) is indicative of hyperphosphatemia, though further tests may be needed to identify the underlying cause of the elevated phosphate levels. [5]

  5. Diabetes medication - Wikipedia

    en.wikipedia.org/wiki/Diabetes_medication

    Drugs used in diabetes treat types of diabetes mellitus by decreasing glucose levels in the blood. With the exception of insulin , most GLP-1 receptor agonists ( liraglutide , exenatide , and others), and pramlintide , all diabetes medications are administered orally and are thus called oral hypoglycemic agents or oral antihyperglycemic agents.

  6. Unicycive Therapeutics Announces U.S. FDA Acceptance of the ...

    lite.aol.com/tech/story/0022/20241111/9270851.htm

    Based on a survey conducted in 2022, Nephrologists stated that the greatest unmet need in the treatment of hyperphosphatemia with phosphate binders is a lower pill burden and better patient compliance. 1 The global market opportunity for treating hyperphosphatemia is expected to exceed $2.5 billion, with the United States accounting for more ...

  7. Sucroferric oxyhydroxide - Wikipedia

    en.wikipedia.org/wiki/Sucroferric_oxyhydroxide

    When kidney function is impaired, phosphate excretion declines. Without specific treatment, hyperphosphataemia occurs almost universally, despite dietary phosphate restriction and conventional dialysis treatment. [12] [13] In patients on dialysis, hyperphosphataemia is an independent risk factor for fractures, cardiovascular disease and mortality.

  1. Ads

    related to: hyperphosphatemia treatment nice list of drugs for diabetes